Advertisement

Topics

OMEICOS Therapeutics GmbH Company Profile

19:43 EDT 20th March 2019 | BioPortfolio

OMEICOS Therapeutics is a spin-off company from the Max Delbrück Center for Molecular Medicine (MDC) in Berlin. The company has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids, that have the potential to treat inflammatory, cardiovascular, and other diseases. Epoxyeicosanoids as a newly described class of bioactive lipid mediators activate cell type-specific endogenous pathways that promote organ and tissue protection. OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. OMEICOS’ technology is based on ground-breaking scientific results in the field of omega-3 fatty acid metabolism and physiology obtained by the companies’ founders Drs. Wolf-Hagen Schunck, John. R. Falck, Dominik Müller and Robert Fischer. www.omeicos.com


News Articles [994 Associated News Articles listed on BioPortfolio]

OMEICOS Therapeutics Closes €17m Series C Financing

OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today a...

OMEICOS closes €17mm Series C

OMEICOS Therapeutics GMBH (small-molecule therapies for cardiovascular and ophthalmic diseases) raised €17mm ($19.5mm) in its Series C financing led by new backer Forbion, which was joined by return...

OMEICOS Therapeutics Strengthens Board of Directors with the Appointment of Christian Schetter

-- Addition of 2nd independent board member positions OMEICOS well for future value creation -- OMEICOS Therapeutics, a biopharmaceutical company developing first-in-cl...

OMEICOS Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation

-- Proceeds provide OMEICOS with the financial runway to conduct the Phase II Study PROMISE-AF and continue expansion into ophthalmology through US subsidiary -- OMEICO...

Forbion Leads €17M Series C Financing of Omeicos Therapeutics

Forbion invests €12.5m from its recently launched Forbion IV fund OMEICOS is pioneering the development of stable analogs of omega-3 fatty acid metabol...

OMEICOS Therapeutics GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryOMEICOS Therapeutics GmbH OMEICOS is a biopharmaceutical company that develops small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases. The compan...

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Drugs and Medications [42 Associated Drugs and Medications listed on BioPortfolio]

La prairie switzerland [juvena produits de beaute gmbh]

Package.Label Principle Display Panel

Kynamro [kastle therapeutics, llc]

NA

Tobramycin [holopack verpackungstechnik gmbh]

Tobramycin Inhalation Solution (300 mg/5 mL)

Lonhala [holopack verpackungstechnik gmbh]

Glycopyrrolate Inhalation Solution (25 µg/mL)

Etoposide [thymoorgan gmbh pharmazir & co. k.g]

Etoposide Injection, USP

PubMed Articles [463 Associated PubMed Articles listed on BioPortfolio]

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Response to Chua et al. re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study".

Clinical Trials [226 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Companies [1840 Associated Companies listed on BioPortfolio]

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics is a spin-off company from the Max Delbrück Center for Molecular Medicine (MDC) in Berlin. The company has discovered a series of metabolically robust synt...

OMEICOS Therapeutics

OMEICOS Therapeutics is a spin-off company from the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. The company has discovered a series of metabolically robust synthe...

SCT Spinal Cord Therapeutics GmbH

SCT Spinal Cord Therapeutics GmbH stands for pioneering the therapy of acute and chronic Spinal Cord Injuries (SCI) with its proprietary technology platform: the Regeneration Promoting Treatment (RPT)...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Isarna Therapeutics GmbH

Isarna Therapeutics has an unmatched commitment to developing TGF-β inhibitors that stimulate the human immune system to effectively fight cancer. Isarna Therapeutics are advancing a unique pip...

More Information about "OMEICOS Therapeutics GmbH" on BioPortfolio

We have published hundreds of OMEICOS Therapeutics GmbH news stories on BioPortfolio along with dozens of OMEICOS Therapeutics GmbH Clinical Trials and PubMed Articles about OMEICOS Therapeutics GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OMEICOS Therapeutics GmbH Companies in our database. You can also find out about relevant OMEICOS Therapeutics GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record